by GL Sciences
Inertsil ODS-4
The Most Deactivated Column Ever Made
GL Sciences’ newly-developed chemical bonding technology allows Inertsil ODS-4 to provide high efficiency and good peak shape where competitive columns fail. For example, in the examples at right, Inertsil ODS-4 is compared with competitive ODS phases for the analysis of basic and acidic compounds. Where other columns show poor peak shape, often with secondary interactions that result in prolonged retention, Inertsil ODS-4 delivers symmetric peaks with high efficiency.
Inertsil ODS-4 (and C8-4) is also available in 2 micron particle sizes for UHPLC.
| Vendor | GL Sciences | Max Pressure | 2900 |
| Brand | Inertsil ODS-4 | Surface Area | 450 |
| Modifification | Silica/C18 | Carbon Load, % | 11.0 |
| Mode | Reversed-Phase | Endcapped | Yes |
| Particle Size | Operating Temperature | 60 | |
| Length | pH stability from | 2.0 | |
| Internal Diameter | pH stability to | 7.5 | |
| Pore size | 100 |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| Orochem | Matrix C18 | Reversed-Phase | Silica/C18 | 4.6 mm | 50 mm | 3.0 μm | 100 Å | On request |
| BISCHOFF | ProntoSIL 120-10-C18 ace-EPS | Reversed-Phase | Silica/C18 | 4.6 mm | 250 mm | 10.0 μm | 120 Å | On request |
| BISCHOFF | ProntoSIL 120-10-C18 H | Reversed-Phase | Silica/C18 | 4.6 mm | 200 mm | 10.0 μm | 120 Å | On request |
| Phenomenex | Bondclone C18 | Reversed-Phase | Silica/C18 | 3.9 mm | 250 mm | 10.0 μm | 148 Å | On request |
| Agilent Technologies | Agilent Pursuit | Reversed-Phase | Silica/C18 | 4.0 mm | 50 mm | 5.0 μm | 180 Å | On request |
| Agilent Technologies | ZORBAX Stablebond | Reversed-Phase | Silica/C18 | 4.0 mm | 250 mm | 3.5 μm | 80 Å | On request |
| MACHEREY-NAGEL | NUCLEODUR C18 HTEC | Reversed-Phase | Silica/C18 | 3.0 mm | 50 mm | 3.0 μm | 110 Å | 439.00 |
| Agilent Technologies | ZORBAX Eclipse Plus | Reversed-Phase | Silica/C18 | 4.0 mm | 75 mm | 1.8 μm | 95 Å | On request |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
